Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31


Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.

Cooney T, Lane A, Bartels U, Bouffet E, Goldman S, Leary SES, Foreman NK, Packer RJ, Broniscer A, Minturn JE, Shih CS, Chintagumpala M, Hassall T, Gottardo NG, Dholaria H, Hoffman L, Chaney B, Baugh J, Doughman R, Leach JL, Jones BV, Fouladi M, Warren KE, Monje M.

Neuro Oncol. 2017 Sep 1;19(9):1279-1280. doi: 10.1093/neuonc/nox107. No abstract available.


19-Year-Old Male with Headaches and a Possible Seizure.

Nasrallah MP, Nasrallah IM, Prelack MS, Johnson MO, Lewis TB, Rubenstein M, Minturn JE, Desai A, Marcotte P, Santi M, Martinez-Lage M.

Brain Pathol. 2017 Jul;27(4):557-558. doi: 10.1111/bpa.12529. No abstract available.


Neuroplastic Response After Radiation Therapy for Pediatric Brain Tumors: A Pilot Study.

Armstrong CL, Fisher MJ, Li Y, Lustig RA, Belasco JB, Minturn JE, Hill-Kayser CE, Batra S, Phillips PC.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):991-998. doi: 10.1016/j.ijrobp.2016.01.013. Epub 2016 Mar 17.


Carboplatin Rechallenge After Hypersensitivity Reactions in Pediatric Patients With Low-Grade Glioma.

Shah AC, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang TI, Cole KA, Waanders AJ, Pollack R, Didomenico C, Wildes C, Fisher MJ.

Pediatr Blood Cancer. 2016 Jan;63(1):21-6. doi: 10.1002/pbc.25697. Epub 2015 Jul 31.


Gliomas in children.

Minturn JE, Fisher MJ.

Curr Treat Options Neurol. 2013 Jun;15(3):316-27. doi: 10.1007/s11940-013-0225-x.


AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.

Iyer R, Varela CR, Minturn JE, Ho R, Simpson AM, Light JE, Evans AE, Zhao H, Thress K, Brown JL, Brodeur GM.

Cancer Chemother Pharmacol. 2012 Sep;70(3):477-86. doi: 10.1007/s00280-012-1879-x. Epub 2012 May 24.


Clinical significance of NTRK family gene expression in neuroblastomas.

Light JE, Koyama H, Minturn JE, Ho R, Simpson AM, Iyer R, Mangino JL, Kolla V, London WB, Brodeur GM.

Pediatr Blood Cancer. 2012 Aug;59(2):226-32. doi: 10.1002/pbc.23343. Epub 2011 Oct 11.


A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.

Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE.

J Neurooncol. 2012 Feb;106(3):643-9. doi: 10.1007/s11060-011-0709-z. Epub 2011 Oct 4.


A rare case of ectopic recurrence of a craniopharyngioma diagnosed 17 years after initial presentation.

de Blank PM, Minturn JE.

J Pediatr Hematol Oncol. 2011 Jul;33(5):392-7. doi: 10.1097/MPH.0b013e31820acfb2.


Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.

Norris RE, Minturn JE, Brodeur GM, Maris JM, Adamson PC.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1469-75. doi: 10.1007/s00280-011-1623-y. Epub 2011 Apr 12.


The effect of P75 on Trk receptors in neuroblastomas.

Ho R, Minturn JE, Simpson AM, Iyer R, Light JE, Evans AE, Brodeur GM.

Cancer Lett. 2011 Jun 1;305(1):76-85. doi: 10.1016/j.canlet.2011.02.029. Epub 2011 Mar 17.


Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM.

Cancer Chemother Pharmacol. 2011 Oct;68(4):1057-65. doi: 10.1007/s00280-011-1581-4. Epub 2011 Feb 22.


Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.

Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE.

Neuro Oncol. 2011 Mar;13(3):298-306. doi: 10.1093/neuonc/noq202.


The genetic landscape of the childhood cancer medulloblastoma.

Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE.

Science. 2011 Jan 28;331(6016):435-9. doi: 10.1126/science.1198056. Epub 2010 Dec 16.


Differential aminoacylase expression in neuroblastoma.

Long PM, Stradecki HM, Minturn JE, Wesley UV, Jaworski DM.

Int J Cancer. 2011 Sep 15;129(6):1322-30. doi: 10.1002/ijc.25798. Epub 2011 Apr 1.


A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.

Minturn JE, Janss AJ, Fisher PG, Allen JC, Patti R, Phillips PC, Belasco JB.

Pediatr Blood Cancer. 2011 Jan;56(1):39-44. doi: 10.1002/pbc.22690.


Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma.

Iyer R, Evans AE, Qi X, Ho R, Minturn JE, Zhao H, Balamuth N, Maris JM, Brodeur GM.

Clin Cancer Res. 2010 Mar 1;16(5):1478-85. doi: 10.1158/1078-0432.CCR-09-1531. Epub 2010 Feb 23.


Trk receptor expression and inhibition in neuroblastomas.

Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE.

Clin Cancer Res. 2009 May 15;15(10):3244-50. doi: 10.1158/1078-0432.CCR-08-1815. Epub 2009 May 5. Review.


Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor.

Ho R, Minturn JE, Hishiki T, Zhao H, Wang Q, Cnaan A, Maris J, Evans AE, Brodeur GM.

Cancer Res. 2005 Nov 1;65(21):9868-75.


Resistance to chemotherapy mediated by TrkB in neuroblastomas.

Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM.

Cancer Res. 2002 Nov 15;62(22):6462-6.


Isoform-specific expression of sodium channels in astrocytes in vitro: immunocytochemical observations.

Black JA, Westenbroek R, Minturn JE, Ransom BR, Catterall WA, Waxman SG.

Glia. 1995 Jun;14(2):133-44.


Early postmitotic neurons transiently express TOAD-64, a neural specific protein.

Minturn JE, Geschwind DH, Fryer HJ, Hockfield S.

J Comp Neurol. 1995 May 8;355(3):369-79.


Dynamic aspects of sodium channel expression in astrocytes.

Waxman SG, Sontheimer H, Black JA, Minturn JE, Ransom BR.

Adv Neurol. 1993;59:135-55. Review. No abstract available.


The expression of sodium channels in astrocytes in situ and in vitro.

Black JA, Sontheimer H, Minturn JE, Ransom BR, Waxman SG.

Prog Brain Res. 1992;94:89-107. Review. No abstract available.


Sodium channel expression in optic nerve astrocytes chronically deprived of axonal contact.

Minturn JE, Sontheimer H, Black JA, Ransom BR, Waxman SG.

Glia. 1992;6(1):19-29.


Two types of Na(+)-currents in cultured rat optic nerve astrocytes: changes with time in culture and with age of culture derivation.

Sontheimer H, Minturn JE, Black JA, Ransom BR, Waxman SG.

J Neurosci Res. 1991 Oct;30(2):275-87.


Cell coupling is restricted to subpopulations of astrocytes cultured from rat hippocampus and optic nerve.

Sontheimer H, Minturn JE, Ransom BR, Black JA, Cornell-Bell AH, Waxman SG.

Ann N Y Acad Sci. 1991;633:592-6. No abstract available.


Membrane-associated sodium channels and cytoplasmic precursors in glial cells. Immunocytochemical, electrophysiological, and pharmacological studies.

Minturn JE, Sontheimer H, Black JA, Angelides KJ, Ransom BR, Ritchie JM, Waxman SG.

Ann N Y Acad Sci. 1991;633:255-71. Review. No abstract available.


Specificity of cell-cell coupling in rat optic nerve astrocytes in vitro.

Sontheimer H, Minturn JE, Black JA, Waxman SG, Ransom BR.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9833-7.


Supplemental Content

Loading ...
Support Center